Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
ENDRA Life Sciences is a diagnostics & research business based in the US. ENDRA Life Sciences shares (NDRA) are listed on the NASDAQ and all prices are listed in US Dollars. ENDRA Life Sciences employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $4.15 |
|---|---|
| 52-week range | $3.16 - $13.00 |
| 50-day moving average | $4.26 |
| 200-day moving average | $5.17 |
| Wall St. target price | $92.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.28 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.15 from 2023-01-25
| 1 week (2023-01-20) | -10.17% |
|---|---|
| 1 month (2022-12-23) | -23.00% |
| 3 months (2022-10-27) | 1,464.86% |
| 6 months (2022-07-27) | 1,510.40% |
| 1 year (2022-01-27) | 591.67% |
|---|---|
| 2 years (2021-01-27) | 88.64% |
| 3 years (2020-01-27) | 150.00% |
| 5 years (2018-01-26) | 41.16% |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -58.38% |
| Return on equity TTM | -111.25% |
| Profit margin | 0% |
| Book value | $3.23 |
| Market capitalisation | $13.1 million |
TTM: trailing 12 months
We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months.
ENDRA Life Sciences's shares were split on a 1:20 basis on 9 December 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ENDRA Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ENDRA Life Sciences shares which in turn could have impacted ENDRA Life Sciences's share price.
Over the last 12 months, ENDRA Life Sciences's shares have ranged in value from as little as $3.159 up to $13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ENDRA Life Sciences's is 0.947. This would suggest that ENDRA Life Sciences's shares are less volatile than average (for this exchange).
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
